Search results
Lupin shares up 0.08% as Sensex rises
The Economic Times· 4 days agoEarlier in the day, the stock witnessed a gap down start to the session. The stock quoted a 52-week high price of Rs 1727.9 and a 52-week low of Rs...
Stocks in news: Adani Ports, Cipla, Prestige Estates, MCX, Lupin
The Economic Times· 6 days agoPositive growth in domestic markets for the third consecutive week with a focus on Adani Ports,...
USFDA gives nod to Lupin’s generic formulation to treat eye condition
Financial Express· 2 days agoOlopatadine Hydrochloride Ophthalmic Solution USP (RLD Pataday) had an estimated annual sale of USD...
Shares of Lupin rise as Nifty gains
The Economic Times· 2 days agoIt hit a high of Rs 1601.6 and low of Rs 1576.0 during the session. The stock quoted a 52-week high price of Rs 1727.9 and a low of Rs 875.05. The return on equity for the stock stood at 13.39 ...
PLI scheme for obesity, diabetes drugs likely by 2026: Report
Business Today· 21 hours agoIndian pharma companies such as Dr. Reddy's Laboratories, Lupin, Zydus Cadila, and Sun Pharma are...
EU top court rejects Servier appeal against EU antitrust fine - ET LegalWorld
The Economic Times· 2 days agoEurope's top court on Thursday rejected French drugmaker Servier's appeal against a finding by EU antitrust regulators a decade ago that its pay-for-delay deals with generic rivals were anti-competitive.
Drugmaker Servier loses EU court fight over pay-for-delay deals - ET HealthWorld | Pharma
The Economic Times· 2 days agoBlood Pressure Medicine: "The Court dismisses the appeals of Lupin, Niche Generics, Unichem...
Stock market update: Nifty Pharma index advances 1.11%
The Economic Times· 1 day agoThe Nifty Pharma index closed 1.11 per cent up at 19731.55.
EU top court rejects drugmaker Servier appeal against EU antitrust fine
Business Standard India· 2 days agoThe European Commission handed down the 331 million euro ($354 million) fine in 2014 to Servier, as...
PLI scheme to make obesity, diabetes drugs GLP-1 coming in 2026
CNBC Awaaz· 1 day agoGlucagon-like peptide-1 (GLP-1) are a category of drugs used in the treatment of type 2 diabetes and...
